GENZYME EXPANDS ITS RESEARCH AND MANUFACTURING PRESENCE IN MASSACHUSETTS

Genzyme Corp. (NASDAQ:GENZ) announced today the start of construction on an innovative new science building that is a signature component of a $210 million investment the company is making in its Massachusetts research and manufacturing operations. This includes the construction of a new research facility in Waltham and a major expansion of the company's flagship protein manufacturing facility in Allston.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/f0ea5f6405c59e6e39560571e4569ae2.html)